Aethlon Medical
AEMD
12 hedge funds and large institutions have $481K invested in Aethlon Medical in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 8 closing their positions.
0.27% more ownership
Funds ownership: 0.04% → 0.31% (+0.27%)
25% less funds holding
Funds holding: 16 → 12 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
60% less capital invested
Capital invested by funds: $1.21M → $481K (-$729K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$17.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.88K |
| 3 |
Morgan Stanley
New York
|
+$805 |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$805 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$134 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$11.2K |
| 3 |
AFGAS
Allegiance Financial Group Advisory Services
Vienna,
Virginia
|
-$10.7K |
| 4 |
Two Sigma Investments
New York
|
-$8.13K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.6K |
AEMD Hedge Fund Activity: Q2 2025 in Review
12 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2025, worth a combined $481K — down 60% from $1.21M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AEMD and 4 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Armistice Capital, adding an estimated $17.4K. The largest seller was UBS Group, cutting an estimated $18K.
- 12 institutional investors held Aethlon Medical (AEMD) as of Q2 2025, down from 16 in Q1 2025.
- Funds reported $481K of Aethlon Medical stock for Q2 2025, down 60% quarter-over-quarter.
- 4 funds opened new Aethlon Medical positions in Q2 2025 and 8 closed out, a net change of -4 holders.
- The largest Aethlon Medical buyer in Q2 2025 was Armistice Capital, an estimated $17.4K added.
- The largest Aethlon Medical seller in Q2 2025 was UBS Group, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2025.